Skip to main content
. 2018 Mar 19;19(3):904. doi: 10.3390/ijms19030904
AR androgen receptor
CRPC castration-resistant prostate cancer
PSA prostate specific antigen
EMT epithelial-mesenchymal-transition
MET mesenchymal epithelial-transition
TGF-β transforming growth factor-β
DHT dihydrotestosterone
ADT androgen deprivation therapy
CDK cyclin dependent kinases
ECM extracellular matrix
MDSCs Myeloid-derived suppressor cells
CAFs Cancer-associated fibroblasts
VEGF Vascular endothelial growth factor
IGF insulin growth factor
IGFBP3 Insulin growth factor binding protein-3